Condition: Urolithiasis · Sponsor: Neopharm Bulgaria Ltd.
The purpose of this study is to evaluate the efficacy of a specialized formula of phytotherapeutic extracts (Neorenal Forte) aiding the complete elimination of residual fragments after fURS in adults.
This description comes directly from the study's public registry record.
Margarita Futekova · +359 888 151 579 · m.futekova@neopharm.bg
Stefan Tunev, PhD · +359 888 786 540 · s.tunev@neopharm.bg
Always discuss trial participation with your own doctor first.
| MHAT "Heart and Brain" | Burgas, Bulgaria | Recruiting |
| UMHAT "Dr. Georgi Stranski" | Pleven, Bulgaria | Recruiting |
| University Hospital for Active Treatment "Saint Marina" | Pleven, Bulgaria | Recruiting |
| UMHAT "St. George" | Plovdiv, Bulgaria | Recruiting |
| UMHAT Kaspela | Plovdiv, Bulgaria | Recruiting |
| UMHAT "Alexandrovska" | Sofia, Bulgaria | Recruiting |
| Military Medical Academy | Sofia, Bulgaria | Recruiting |
| UMBALSM "N. I. Pirogov" | Sofia, Bulgaria | Recruiting |
| UMHAT "Sofiamed" | Sofia, Bulgaria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06651294